| scholarly article | Q13442814 |
| P2093 | author name string | Fried M | |
| Duffy PE | |||
| P433 | issue | 5267 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 1502-1504 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta | |
| P478 | volume | 272 |
| Q53818900 | '2TM proteins': an antigenically diverse superfamily with variable functions and export pathways. |
| Q40982669 | A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection |
| Q28547338 | A Unique Virulence Gene Occupies a Principal Position in Immune Evasion by the Malaria Parasite Plasmodium falciparum |
| Q43924224 | A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses |
| Q49431533 | A brief review on features of falciparum malaria during pregnancy |
| Q47907843 | A distinct 5' flanking var gene region regulates Plasmodium falciparum variant erythrocyte surface antigen expression in placental malaria |
| Q36737343 | A model of parity-dependent immunity to placental malaria. |
| Q40089629 | A new method for sequencing the hypervariable Plasmodium falciparum gene var2csa from clinical samples |
| Q34425614 | A novel histological grading scheme for placental malaria applied in areas of high and low malaria transmission |
| Q27972747 | A novel protein kinase family in Plasmodium falciparum is differentially transcribed and secreted to various cellular compartments of the host cell |
| Q34147732 | A plasma survey using 38 PfEMP1 domains reveals frequent recognition of the Plasmodium falciparum antigen VAR2CSA among young Tanzanian children |
| Q34276761 | A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells |
| Q42680364 | A semi-synthetic glycosaminoglycan analogue inhibits and reverses Plasmodium falciparum cytoadherence. |
| Q36933288 | A simple protocol for platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes in a resource poor setting |
| Q34360455 | A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. |
| Q37298050 | A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies |
| Q42127279 | A var gene promoter implicated in severe malaria nucleates silencing and is regulated by 3' untranslated region and intronic cis-elements |
| Q46558019 | A versatile, high through-put, bead-based phagocytosis assay for Plasmodium falciparum |
| Q33849072 | A well-conserved Plasmodium falciparum var gene shows an unusual stage-specific transcript pattern. |
| Q39189734 | ABO blood group phenotypes and Plasmodium falciparum malaria: unlocking a pivotal mechanism. |
| Q35016351 | ABO phenotypes and malaria related outcomes in mothers and babies in The Gambia: a role for histo-blood groups in placental malaria? |
| Q36793324 | Abundance of megalin and Dab2 is reduced in syncytiotrophoblast during placental malaria, which may contribute to low birth weight |
| Q37675691 | Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery |
| Q90246137 | Adhesion between P. falciparum infected erythrocytes and human endothelial receptors follows alternative binding dynamics under flow and febrile conditions |
| Q36938125 | Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malaria |
| Q37036133 | Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria |
| Q35855593 | Adhesion specificities of Plasmodium falciparum-infected erythrocytes involved in the pathogenesis of pregnancy-associated malaria |
| Q33538651 | Adhesive proteins of the malaria parasite |
| Q39050802 | Adipose Tissue: A Safe Haven for Parasites? |
| Q21032463 | Advances and challenges in malaria vaccine development |
| Q64055939 | Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors |
| Q35381190 | An analysis of the binding characteristics of a panel of recently selected ICAM-1 binding Plasmodium falciparum patient isolates |
| Q28482962 | An image-based drug susceptibility assay targeting the placental sequestration of Plasmodium falciparum-infected erythrocytes |
| Q43643657 | An in vitro microassay to assess the ability of Plasmodium falciparum-infected erythrocytes to bind to the human syncytiotrophoblast |
| Q33396980 | An upstream open reading frame controls translation of var2csa, a gene implicated in placental malaria |
| Q24792921 | Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates |
| Q47996636 | Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain |
| Q57153246 | Antenatal Practices Ineffective at Prevention of Plasmodium falciparum Malaria during Pregnancy in a Sub-Saharan Africa Region, Nigeria |
| Q36718654 | Anti-malarial IgG subclasses pattern and FcγRIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women. |
| Q24793948 | Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A |
| Q36374795 | Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns |
| Q36576445 | Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women |
| Q36804761 | Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue |
| Q33822296 | Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates |
| Q37036128 | Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets |
| Q33636850 | Antibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum |
| Q54258919 | Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes. |
| Q37202370 | Antibody responses to Plasmodium falciparum and Plasmodium vivax blood-stage and sporozoite antigens in the postpartum period |
| Q30603697 | Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria |
| Q36789977 | Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies |
| Q35946430 | Antigenic diversity and immune evasion by malaria parasites. |
| Q40918892 | Antigenic variation and immune evasion in Plasmodium falciparum malaria |
| Q24672872 | Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family |
| Q24533320 | Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum |
| Q36644765 | Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. |
| Q36694562 | Assessment of the usage and effectiveness of intermittent preventive treatment and insecticide-treated nets on the indicators of malaria among pregnant women attending antenatal care in the Buea Health District, Cameroon |
| Q33828486 | Association of Plasmodium falciparum with Human Endothelial Cells in vitro |
| Q33894907 | Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor |
| Q33654974 | Asymptomatic Plasmodium falciparum malaria in pregnant women in the Chittagong Hill Districts of Bangladesh |
| Q44143928 | Attraction of mosquitoes to pregnant women |
| Q39692692 | Attractiveness of pregnant women to the malaria vector, Anopheles arabiensis, in Sudan |
| Q37713335 | B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites |
| Q34721210 | Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes |
| Q47880785 | Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein |
| Q33766474 | Biological and biochemical characteristics of cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate. |
| Q34479077 | Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. |
| Q92563835 | Biosensors for Detection of Human Placental Pathologies: A Review of Emerging Technologies and Current Trends |
| Q33378580 | Blood coagulation, inflammation, and malaria |
| Q48006458 | Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype |
| Q38725258 | Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration |
| Q33420846 | C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria. |
| Q35035430 | CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells |
| Q33487651 | Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya |
| Q34487662 | Carbohydrate sulfotransferases: mediators of extracellular communication |
| Q40398384 | Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36. |
| Q37846879 | Cell biology and immunology of malaria |
| Q36222486 | Cellular adhesive phenomena in apicomplexan parasites of red blood cells |
| Q24799346 | Cellular immune response to Plasmodium falciparum after pregnancy is related to previous placental infection and parity |
| Q90341629 | Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it |
| Q38690668 | Cerebral malaria--clinical manifestations and pathogenesis. |
| Q35865612 | Changes in var gene mRNA levels during erythrocytic development in two phenotypically distinct Plasmodium falciparum parasites |
| Q40881172 | Characterisation of the chondroitin sulphate of Saimiri brain microvascular endothelial cells involved in Plasmodium falciparum cytoadhesion |
| Q36579280 | Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line |
| Q37625184 | Characterization of human placental glycosaminoglycans and regional binding to VAR2CSA in malaria infected erythrocytes |
| Q31440647 | Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta |
| Q42157454 | Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers |
| Q54231990 | Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets. |
| Q38654292 | Chondroitin sulfate disaccharides modified the structure and function of the murine gut microbiome under healthy and stressed conditions |
| Q48037253 | Chondroitin sulfate of thrombomodulin is an adhesion receptor for Plasmodium falciparum-infected erythrocytes |
| Q35855583 | Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression |
| Q34934975 | Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy. |
| Q34199064 | Chondroitin sulfate synthase-2. Molecular cloning and characterization of a novel human glycosyltransferase homologous to chondroitin sulfate glucuronyltransferase, which has dual enzymatic activities |
| Q34220883 | Chondroitin sulfate synthase-3. Molecular cloning and characterization |
| Q46359668 | Chondroitin sulphate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes |
| Q36437968 | Chondroitin-4-sulfate impairs in vitro and in vivo cytoadherence of Plasmodium falciparum infected erythrocytes. |
| Q33924720 | Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family |
| Q36243041 | Clinical and molecular aspects of severe malaria |
| Q40204991 | Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae |
| Q41549587 | Clinical trials of malaria vaccines: progress and prospects. |
| Q40528939 | Cobra cardiotoxin and phospholipase A2 as GAG-binding toxins: on the path from structure to cardiotoxicity and inflammation |
| Q38805246 | Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies |
| Q39181835 | Commonly recognised Plasmodium falciparum parasites cause cerebral malaria |
| Q35016104 | Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties |
| Q39066692 | Comparison of functional assays used in the clinical development of a placental malaria vaccine |
| Q37211417 | Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment |
| Q92500040 | Composition of the gut microbiota transcends genetic determinants of malaria infection severity and influences pregnancy outcome |
| Q36509858 | Computational Fluid Dynamic Simulations of Maternal Circulation: Wall Shear Stress in the Human Placenta and Its Biological Implications |
| Q36775697 | Congenital Plasmodium falciparum infection in neonates in Muheza District, Tanzania |
| Q36762607 | Congenital infections associated with international travel during pregnancy |
| Q33769127 | Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of var2csa |
| Q35200263 | Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind |
| Q36202059 | Cytoadherence and severe malaria. |
| Q39511222 | Cytoadherence of Babesia bovis-infected erythrocytes to bovine brain capillary endothelial cells provides an in vitro model for sequestration |
| Q35545174 | Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta |
| Q46481957 | Cytoadherence of Plasmodium falciparum-infected erythrocytes in the human placenta |
| Q37408511 | Cytoadherence of erythrocytes invaded by Plasmodium falciparum: quantitative contact-probing of a human malaria receptor |
| Q34116419 | Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific pfemp-1 expression in parasites from children with cerebral malaria |
| Q33730132 | Cytoadherence, pathogenesis and the infected red cell surface in Plasmodium falciparum. |
| Q47873473 | Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes |
| Q34876859 | Cytoadhesion of Plasmodium falciparum-infected erythrocytes to chondroitin-4-sulfate is cooperative and shear enhanced |
| Q36189938 | Cytoadhesion to gC1qR through Plasmodium falciparum Erythrocyte Membrane Protein 1 in Severe Malaria |
| Q34355453 | DC8 and DC13 var genes associated with severe malaria bind avidly to diverse endothelial cells |
| Q35165007 | DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses |
| Q34548667 | Decoding the language of var genes and Plasmodium falciparum sequestration |
| Q47901144 | Definition of the minimal domain of CIDR1alpha of Plasmodium falciparum PfEMP1 for binding CD36. |
| Q39212819 | Demonstration of specific binding of heparin to Plasmodium falciparum-infected vs. non-infected red blood cells by single-molecule force spectroscopy |
| Q34994012 | Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside |
| Q34498103 | Designing a VAR2CSA-based vaccine to prevent placental malaria |
| Q35623113 | Determinants of Anaemia in Pregnancy in Sekyere West District, Ghana |
| Q38519513 | Developing vaccines to prevent malaria in pregnant women |
| Q34002177 | Development of antibodies against chondroitin sulfate A-adherent Plasmodium falciparum in pregnant women |
| Q39245566 | Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report |
| Q35947173 | Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan |
| Q15295131 | Diagnosis of Plasmodium falciparum Malaria at Delivery: Comparison of Blood Film Preparation Methods and of Blood Films with Histology |
| Q39007232 | Diagnosis of hypertensive disorders of pregnancy in sub-Saharan Africa: a poorly assessed but increasingly important issue. |
| Q37242538 | Diagnostic comparison of malaria infection in peripheral blood, placental blood and placental biopsies in Cameroonian parturient women |
| Q48022703 | Different stages in drug development for muscle-invasive bladder cancer |
| Q44227448 | Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. |
| Q34310322 | Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers |
| Q34003061 | Differential binding of clonal variants of Plasmodium falciparum to allelic forms of intracellular adhesion molecule 1 determined by flow adhesion assay |
| Q35785754 | Differential changes in Plasmodium falciparum var transcription during adaptation to culture |
| Q27349502 | Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA |
| Q33532592 | Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area |
| Q35692513 | Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women |
| Q35739059 | Differential roles of inflammation and apoptosis in initiation of mid-gestational abortion in malaria-infected C57BL/6 and A/J mice |
| Q46646980 | Discovery of a Small-Molecule Modulator of Glycosaminoglycan Sulfation. |
| Q33299476 | Disruption of var2csa gene impairs placental malaria associated adhesion phenotype |
| Q33274651 | Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells |
| Q33878520 | Diversity and functions of glycosaminoglycan sulfotransferases |
| Q56362112 | Down-selection of the VAR2CSA DBL1-2 expressed in as a lead antigen for placental malaria vaccine development |
| Q34151684 | Dual stage synthesis and crucial role of cytoadherence-linked asexual gene 9 in the surface expression of malaria parasite var proteins |
| Q33721310 | Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy |
| Q57281219 | Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin |
| Q30979156 | Dysregulation of angiopoietins is associated with placental malaria and low birth weight |
| Q33733730 | Effect of IPTp on Plasmodium falciparum antibody levels among pregnant women and their babies in a sub-urban coastal area in Ghana |
| Q40129113 | Effect of cytokine treatment on the in vitro expression of the P. falciparum adhesion receptor chondroitin-4-sulphate on the surface of human choriocarcinoma (BeWo) cells |
| Q46543432 | Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal |
| Q46329914 | Effect of submicroscopic or polyclonal Plasmodium falciparum infection on mother and gestation product: systematic review |
| Q39309842 | Effects of Plasmodium vivax malaria in pregnancy |
| Q41452072 | Effects of Pregnancy-associated Malaria on T Cell Cytokines in Cameroonian Women. |
| Q37573034 | Effects of vivax malaria acquired before 20 weeks of pregnancy on subsequent changes in fetal growth |
| Q40522398 | Efficacy of chloroquine plus chlorpheniramine in chloroquine-resistant falciparum malaria during pregnancy in Nigerian women: a preliminary study |
| Q36539570 | Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy |
| Q33263953 | Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration |
| Q44120315 | Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells |
| Q40566323 | Evaluation of Cytokeratin 7 as an accurate intracellular marker with which to assess the purity of human placental villous trophoblast cells by flow cytometry |
| Q40960444 | Evaluation of Pregnancy Malaria Vaccine Candidates: The Binding Inhibition Assay |
| Q33826049 | Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women |
| Q33873623 | Evaluation of the effectiveness and compliance of intermittent preventive treatment (IPT) in the control of malaria in pregnant women in south eastern Nigeria |
| Q30502964 | Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1 |
| Q36539548 | Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA. |
| Q34364093 | Evidence for the involvement of VAR2CSA in pregnancy-associated malaria |
| Q35760573 | Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso |
| Q34002825 | Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A. |
| Q26772866 | Expanding the antimalarial toolkit: Targeting host-parasite interactions |
| Q36100829 | Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. |
| Q36531224 | Expression of a type B RIFIN in Plasmodium falciparum merozoites and gametes |
| Q35689215 | Expression of merozoite surface protein markers by Plasmodium falciparum-infected erythrocytes in peripheral blood and tissues of children with fatal malaria |
| Q34715375 | Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection |
| Q41915828 | Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso |
| Q33919391 | Falciparum malaria: sticking up, standing out and out-standing. |
| Q34154453 | Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes |
| Q36539591 | Fetal responses during placental malaria modify the risk of low birth weight |
| Q61807077 | Fetal-Derived MyD88 Signaling Contributes to Poor Pregnancy Outcomes During Gestational Malaria |
| Q36936419 | Flt1, pregnancy, and malaria: evolution of a complex interaction |
| Q47873714 | Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum |
| Q33622909 | Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion. |
| Q24620671 | Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA |
| Q34095324 | Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies |
| Q93109754 | Functional Antibodies against Placental Malaria Parasites Are Variant Dependent and Differ by Geographic Region |
| Q33603038 | Functional antibodies against VAR2CSA in nonpregnant populations from colombia exposed to Plasmodium falciparum and Plasmodium vivax |
| Q37144998 | Genetic polymorphisms of mannose-binding lectin do not influence placental malaria but are associated with preterm deliveries |
| Q22122524 | Genome sequence of the human malaria parasite Plasmodium falciparum |
| Q37155849 | Glycosaminoglycans and infection. |
| Q34009705 | Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy |
| Q37984496 | HIV and malaria interactions: where do we stand? |
| Q33286064 | HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites |
| Q39052051 | HIV-1 infection and antibodies to Plasmodium falciparum in adults |
| Q34171651 | HIV-1 inhibits phagocytosis and inflammatory cytokine responses of human monocyte-derived macrophages to P. falciparum infected erythrocytes |
| Q36114619 | Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis |
| Q47924606 | Haemozoin as a marker of placental parasitization |
| Q24810377 | Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis |
| Q42156743 | Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor |
| Q40164066 | Heparin: new life for an old drug |
| Q34801927 | Hepatitis E and pregnancy: understanding the pathogenesis |
| Q36088581 | Heterologous Infection of Pregnant Mice Induces Low Birth Weight and Modifies Offspring Susceptibility to Malaria |
| Q34290645 | Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children |
| Q34326742 | High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria |
| Q34075564 | High diversity and rapid changeover of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers |
| Q43941189 | High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women |
| Q36940415 | High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin |
| Q33432676 | High throughput functional assays of the variant antigen PfEMP1 reveal a single domain in the 3D7 Plasmodium falciparum genome that binds ICAM1 with high affinity and is targeted by naturally acquired neutralizing antibodies |
| Q35197372 | High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes |
| Q33806360 | Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta |
| Q34388448 | Host defense and tolerance: unique challenges in the placenta |
| Q42635278 | Host factors that modify Plasmodium falciparum adhesion to endothelial receptors |
| Q44169469 | Host immune evasion strategies of malaria blood stage parasite |
| Q46947890 | Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy |
| Q35211697 | Host-parasite interaction and morbidity in malaria endemic areas |
| Q47877028 | How does Plasmodium falciparum stick to CSA? Let's see in the crystal. |
| Q59330148 | How does malaria in pregnancy impact malaria risk in infants? |
| Q43621915 | How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma |
| Q35156896 | How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate? |
| Q36365306 | Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors |
| Q35780389 | Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts |
| Q61716150 | Human erythrocyte band 3 is a host receptor for glutamic acid-rich protein |
| Q37426131 | Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA |
| Q46405594 | Hyperexpression of ICAM-1 and CD36 in placentas infected with Plasmodium falciparum: a possible role of these molecules in sequestration of infected red blood cells in placentas |
| Q28766797 | Hypertension and maternal-fetal conflict during placental malaria |
| Q39031578 | ICAM-1 can play a major role in mediating P. falciparum adhesion to endothelium under flow |
| Q33634753 | ICAM-1 is a key receptor mediating cytoadherence and pathology in the Plasmodium chabaudi malaria model |
| Q34062601 | IFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women. |
| Q47123632 | IFNGR1 signaling is associated with adverse pregnancy outcomes during infection with malaria parasites |
| Q33849078 | Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodies |
| Q33596242 | Identification of glycosaminoglycan binding domains in Plasmodium falciparum erythrocyte membrane protein 1 of a chondroitin sulfate A-adherent parasite |
| Q33340867 | Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA |
| Q30656207 | Identification of malaria parasite-infected red blood cell surface aptamers by inertial microfluidic SELEX (I-SELEX). |
| Q53819699 | IgM and IgG against Plasmodium falciparum lysate as surrogates of malaria exposure and protection during pregnancy. |
| Q30432532 | IgM, Fc mu Rs, and malarial immune evasion |
| Q46174880 | Imbalanced distribution of IgM and IgG antibodies against Plasmodium falciparum antigens and merozoite surface protein-1 (MSP1) in pregnancy |
| Q33826076 | Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes |
| Q38103059 | Immunobiology of Plasmodium in liver and brain |
| Q35073950 | Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria |
| Q33788169 | Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas |
| Q36498853 | Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum |
| Q34447833 | Immunological processes in malaria pathogenesis. |
| Q64104468 | Impact of Hemoglobin S Trait on Cell Surface Antibody Recognition of -Infected Erythrocytes in Pregnancy-Associated Malaria |
| Q30245481 | Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity |
| Q36539086 | Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria |
| Q35920636 | Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa |
| Q37426283 | Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate's plasma levels of some cytokines known to regulate T cells differentiation and function |
| Q35187064 | Importance and prevention of malaria in pregnancy |
| Q33381611 | In silico identification of specialized secretory-organelle proteins in apicomplexan parasites and in vivo validation in Toxoplasma gondii |
| Q37365754 | In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults |
| Q30984141 | In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins |
| Q33617916 | Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso |
| Q39341627 | Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade |
| Q37204480 | Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. |
| Q36690071 | Induction of crossreactive antibodies against the Plasmodium falciparum variant protein |
| Q34660001 | Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins |
| Q34244920 | Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites |
| Q47861315 | Infected erythrocytes expressing DC13 PfEMP1 differ from recombinant proteins in EPCR-binding function |
| Q37272658 | Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses |
| Q47831862 | Inflammatory reactions in placental blood of Plasmodium falciparum-infected women and high concentrations of soluble E-selectin and a circulating P. falciparum protein in the cord sera |
| Q37201119 | Influence of human chorionic gonadotropin (hCG) on in vitro growth of Plasmodium falciparum |
| Q34973764 | Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides. |
| Q34005689 | Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides |
| Q33756774 | Inhibition of binding of malaria-infected erythrocytes by a tetradecasaccharide fraction from chondroitin sulfate A |
| Q33883564 | Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides |
| Q35913659 | Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1 |
| Q33721891 | Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates |
| Q57784964 | Integrated proteomics reveals apoptosis-related mechanisms associated with placental malaria |
| Q39794107 | Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells |
| Q47151593 | Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso |
| Q37521618 | Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria |
| Q35652102 | Intermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed? |
| Q28486791 | Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring |
| Q35452357 | Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance |
| Q27336415 | Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of Plasmodium-infected erythrocytes |
| Q26799717 | Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach |
| Q33900642 | Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family |
| Q33828414 | Iron overload in Plasmodium berghei-infected placenta as a pathogenesis mechanism of fetal death |
| Q35677598 | Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin |
| Q35106301 | Lack of gender-specific antibody recognition of products from domains of a var gene implicated in pregnancy-associated Plasmodium falciparum malaria |
| Q36510147 | Large screen approaches to identify novel malaria vaccine candidates |
| Q34601747 | Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes |
| Q35541393 | Limited response of NK92 cells to Plasmodium falciparum-infected erythrocytes |
| Q37734391 | Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain |
| Q34239984 | Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission |
| Q28080325 | Malaria Parasites: The Great Escape |
| Q35678578 | Malaria and immunity during pregnancy and postpartum: a tale of two species |
| Q35751895 | Malaria burden in pregnancy at mulago national referral hospital in kampala, Uganda |
| Q37287631 | Malaria diagnostics in clinical trials |
| Q36284603 | Malaria during Pregnancy |
| Q37488243 | Malaria evolution in South Asia: knowledge for control and elimination |
| Q33821137 | Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease |
| Q81266084 | Malaria in pregnancy |
| Q47899839 | Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections |
| Q36717621 | Malaria in pregnancy: pathogenesis and immunity |
| Q36717642 | Malaria in pregnancy: priorities for research |
| Q41990397 | Malaria in pregnancy: the relevance of animal models for vaccine development. |
| Q47896646 | Malaria invades Yorkshire |
| Q34999453 | Malaria pathogenesis: a jigsaw with an increasing number of pieces |
| Q37333056 | Malaria's deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes |
| Q47827320 | Malaria--variety is the price of life. |
| Q92308280 | Malaria-Associated Factors among Pregnant Women in Guinea |
| Q27485634 | Malaria: progress, perils, and prospects for eradication |
| Q28661352 | Malarial parasite diversity in chimpanzees: the value of comparative approaches to ascertain the evolution of Plasmodium falciparum antigens |
| Q48022331 | Matched Placental and Circulating Plasmodium falciparum Parasites are Genetically Homologous at the var2csa ID1-DBL2X Locus by Deep Sequencing |
| Q38741552 | Maternal Microchimerism Predicts Increased Infection but Decreased Disease due to Plasmodium falciparum During Early Childhood |
| Q24814453 | Maternal malaria and gravidity interact to modify infant susceptibility to malaria |
| Q36492379 | Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria |
| Q64985715 | Maternal-Fetal Conflict During Infection: Lessons From a Mouse Model of Placental Malaria. |
| Q61716953 | Maternally derived antibodies to Schizont Egress Antigen-1 and protection of infants from severe malaria |
| Q35533138 | Microbial adherence to and invasion through proteoglycans |
| Q37255276 | Microfluidic approaches to malaria pathogenesis |
| Q27319921 | Microfluidic modeling of cell-cell interactions in malaria pathogenesis |
| Q28071399 | Modeling cytoadhesion of Plasmodium falciparum-infected erythrocytes and leukocytes-common principles and distinctive features |
| Q37702795 | Modulation of dendritic cell responses by parasites: a common strategy to survive |
| Q64076612 | Molecular Principles of Intrauterine Growth Restriction in Plasmodium Falciparum Infection |
| Q35868719 | Molecular aspects of Plasmodium falciparum Infection during pregnancy |
| Q24550715 | Molecular aspects of severe malaria |
| Q41739876 | Molecular basis for evasion of host immunity and pathogenesis in malaria |
| Q34098784 | Molecular basis for the dichotomy in Plasmodium falciparum adhesion to CD36 and chondroitin sulfate A |
| Q34279841 | Molecular basis of severe malaria |
| Q28139047 | Molecular cloning and expression of chondroitin 4-sulfotransferase |
| Q34190504 | Molecular mechanisms of Plasmodium falciparum placental adhesion. |
| Q37018621 | Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control |
| Q47838974 | Motherhood and malaria |
| Q36558721 | Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria |
| Q39571758 | Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria |
| Q40120062 | Multiplexing detection of IgG against Plasmodium falciparum pregnancy-specific antigens |
| Q37002285 | Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy |
| Q34602096 | Murine malaria infection induces fetal loss associated with accumulation of Plasmodium chabaudi AS-infected erythrocytes in the placenta |
| Q37546441 | MyD88 signaling is directly involved in the development of murine placental malaria |
| Q24535094 | N-linked oligosaccharides are required to produce and stabilize the active form of chondroitin 4-sulphotransferase-1 |
| Q37689434 | NK Cells: Uncertain Allies against Malaria |
| Q34614540 | NSR-seq transcriptional profiling enables identification of a gene signature of Plasmodium falciparum parasites infecting children |
| Q35124285 | Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells |
| Q36936271 | Natural selection of FLT1 alleles and their association with malaria resistance in utero |
| Q34194564 | Neonatal and maternal immunological responses to conserved epitopes within the DBL-gamma3 chondroitin sulfate A-binding domain of Plasmodium falciparum erythrocyte membrane protein 1. |
| Q36980850 | New approaches to pathogenesis of malaria in pregnancy. |
| Q36330969 | New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women |
| Q38353755 | New tools to identify var sequence tags and clone full-length genes using type-specific primers to Duffy binding-like domains |
| Q35025223 | Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin |
| Q35165595 | Nonspecific immunoglobulin M binding and chondroitin sulfate A binding are linked phenotypes of Plasmodium falciparum isolates implicated in malaria during pregnancy |
| Q34881813 | Novel Plasmodium falciparum malaria vaccines: evidence-based searching for variant surface antigens as candidates for vaccination against pregnancy-associated malaria |
| Q36073865 | Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria |
| Q37470684 | Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility. |
| Q37271796 | Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris |
| Q36640619 | Overproduction, purification and crystallization of a chondroitin sulfate A-binding DBL domain from a Plasmodium falciparum var2csa-encoded PfEMP1 protein |
| Q89595553 | PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study |
| Q60947070 | Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria |
| Q34292107 | Parasite adhesion and immune evasion in placental malaria. |
| Q38182100 | Parasite dissemination and the pathogenesis of toxoplasmosis |
| Q47727463 | Parasites and pregnancy |
| Q35692279 | Parasitologic Assessment of Two-Dose and Monthly Intermittent Preventive Treatment of Malaria during Pregnancy with Sulphadoxine-Pyrimethamine (IPTP-SP) in Lagos, Nigeria |
| Q34740303 | Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy |
| Q35609294 | Parity-dependent recognition of DBL1X-3X suggests an important role of the VAR2CSA high-affinity CSA-binding region in the development of the humoral response against placental malaria |
| Q35693520 | Pathogens and the placental fortress |
| Q35637028 | Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant women |
| Q38282573 | Perioperative considerations of the patient with malaria |
| Q34484783 | Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery |
| Q43179011 | Phenotypes of Plasmodium falciparum from the peripheral blood of pregnant women |
| Q92632114 | Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA |
| Q35025427 | Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates |
| Q55354236 | Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice. |
| Q27973758 | Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1 |
| Q44424266 | Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana |
| Q33716582 | Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic |
| Q34034060 | Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity |
| Q33738991 | Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight |
| Q91996104 | Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains |
| Q42483373 | Placental pathology in malaria: a histological, immunohistochemical, and quantitative study |
| Q33526296 | Plasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemia |
| Q92528198 | Plasmodium asexual growth and sexual development in the haematopoietic niche of the host |
| Q35812804 | Plasmodium chabaudi AS induces pregnancy loss in association with systemic pro-inflammatory immune responses in A/J and C57BL/6 mice |
| Q35206903 | Plasmodium falciparum adhesion in the placenta |
| Q36555167 | Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. |
| Q36980841 | Plasmodium falciparum during pregnancy: a puzzling parasite tissue adhesion tropism |
| Q33700519 | Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer |
| Q34853037 | Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1. |
| Q91722797 | Plasmodium falciparum infection dysregulates placental autophagy |
| Q43924333 | Plasmodium falciparum infection early in pregnancy has profound consequences for foetal growth |
| Q47675155 | Plasmodium falciparum infection of the placenta affects newborn immune responses |
| Q30940547 | Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women |
| Q37036123 | Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties |
| Q34602087 | Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo |
| Q46949604 | Plasmodium falciparum persists in the placenta after three days' treatment with quinine |
| Q37464100 | Plasmodium falciparum picks (on) EPCR. |
| Q33946646 | Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal |
| Q30042320 | Plasmodium falciparum proteins involved in cytoadherence of infected erythrocytes to chemokine CX3CL1 |
| Q34003113 | Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women |
| Q33325481 | Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression |
| Q33301011 | Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. |
| Q41676911 | Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein |
| Q35098438 | Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor |
| Q37354879 | Plasmodium falciparum: Assessment of parasite-infected red blood cell binding to placental chondroitin proteoglycan and bovine tracheal chondroitin sulfate A. |
| Q47905916 | Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants |
| Q61332555 | Plasmodium falciparum: Pathogenesis, polymorphism and the infected red cell surface |
| Q38861772 | Plasmodium falciparum: analysis of transcribed var gene sequences in natural isolates from the Brazilian Amazon region |
| Q36980846 | Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia |
| Q37188081 | Plasmodium in the postgenomic era: new insights into the molecular cell biology of malaria parasites. |
| Q36155071 | Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women |
| Q31056451 | Plasmodium vivax adherence to placental glycosaminoglycans |
| Q77157550 | Plasmodium-falciparum-infected erythrocytes adhere to immortalized human bone marrow endothelial cells |
| Q34105789 | Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria |
| Q33908405 | Platelets alter gene expression profile in human brain endothelial cells in an in vitro model of cerebral malaria |
| Q34988334 | Positive selection of Plasmodium falciparum parasites with multiple var2csa-type PfEMP1 genes during the course of infection in pregnant women |
| Q38691920 | Pre-clinical and clinical development of the first placental malaria vaccine |
| Q26827604 | Pregnancy and infection |
| Q27005799 | Pregnancy and susceptibility to infectious diseases |
| Q33319580 | Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women |
| Q33963392 | Pregnancy-associated malaria and malaria in infants: an old problem with present consequences |
| Q36399361 | Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines |
| Q92666131 | Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review |
| Q34993578 | Pregnant women are a reservoir of malaria transmission in Blantyre, Malawi |
| Q37172842 | Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon |
| Q36088608 | Prevalence of Malaria and Anemia among Pregnant Women Attending a Traditional Birth Home in Benin City, Nigeria |
| Q44270197 | Prevalence, risk factors and effects of placental malaria in the UMTH, Maiduguri, North-eastern, Nigeria: a cross-sectional study |
| Q35738477 | Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites |
| Q36253322 | Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications |
| Q58831352 | Purification and characterization of fetal bovine serum beta-N-acetyl-D-galactosaminyltransferase and beta-D-glucuronyltransferase involved in chondroitin sulfate biosynthesis |
| Q92523390 | Quantification of malaria antigens PfHRP2 and pLDH by quantitative suspension array technology in whole blood, dried blood spot and plasma |
| Q44825165 | Quantitative computer image analysis of chondroitin sulfate A expression in placentas infected with Plasmodium falciparum |
| Q33769097 | Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae |
| Q97070164 | Rapid activation of distinct members of multigene families in Plasmodium spp |
| Q30381400 | Real-time measurement of Plasmodium falciparum-infected erythrocyte cytoadhesion with a quartz crystal microbalance. |
| Q56355140 | Recent advances in the molecular epidemiology of clinical malaria |
| Q40859266 | Recombinant human thrombomodulin(csa+): a tool for analyzing Plasmodium falciparum adhesion to chondroitin-4-sulfate |
| Q33450639 | Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravida |
| Q35679569 | Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo |
| Q33990390 | Reduced prevalence of placental malaria in primiparae with blood group O |
| Q34633270 | Reduced risk for placental malaria in iron deficient women |
| Q37248735 | Regulatory T cells and the immune pathogenesis of prenatal infection |
| Q37116542 | Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria |
| Q33952181 | Relevant assay to study the adhesion of Plasmodium falciparum-infected erythrocytes to the placental epithelium |
| Q36284299 | Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. |
| Q36713881 | Role of chondroitin-4-sulfate in pregnancy-associated malaria |
| Q46453882 | Rosetting in Plasmodium falciparum: a cytoadherence phenotype with multiple actors |
| Q34675111 | Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia |
| Q92910897 | Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting |
| Q33835894 | Safety and benefits of antenatal oral iron supplementation in low-income countries: a review |
| Q89619474 | Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA) |
| Q34132871 | Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta |
| Q34162904 | Sequence polymorphism, segmental recombination and toggling amino acid residues within the DBL3X domain of the VAR2CSA placental malaria antigen |
| Q29396069 | Sequestration and Tissue Accumulation of Human Malaria Parasites: Can We Learn Anything from Rodent Models of Malaria? |
| Q35666823 | Sequestration: causes and consequences |
| Q29614923 | Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster |
| Q36574313 | Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. |
| Q34111618 | Short-chain aliphatic polysulfonates inhibit the entry of Plasmodium into red blood cells |
| Q44148115 | Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes |
| Q37442983 | Simultaneous transcription of duplicated var2csa gene copies in individual Plasmodium falciparum parasites |
| Q36097316 | Six genes are preferentially transcribed by the circulating and sequestered forms of Plasmodium falciparum parasites that infect pregnant women |
| Q37721429 | Small variant surface antigens and Plasmodium evasion of immunity |
| Q34221892 | Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria |
| Q33842019 | Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome |
| Q91971710 | Sticking for a Cause: The Falciparum Malaria Parasites Cytoadherence Paradigm |
| Q47857297 | Sticky sugars attract malaria to the fetus |
| Q33691325 | Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions |
| Q93006668 | Stringent Selection of Knobby Plasmodium falciparum-Infected Erythrocytes during Cytoadhesion at Febrile Temperature |
| Q27657099 | Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during Pregnancy |
| Q36078717 | Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. |
| Q38300914 | Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity |
| Q38307897 | Structural basis for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin 4-sulfate and design of novel photoactivable reagents for the identification of parasite adhesive proteins |
| Q33320197 | Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA |
| Q37791592 | Structural insights into chondroitin sulfate binding in pregnancy-associated malaria |
| Q47871941 | Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta |
| Q36139430 | Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions |
| Q27653526 | Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A |
| Q34674872 | Structure-function-immunogenicity studies of PfEMP1 domain DBL2βPF11_0521, a malaria parasite ligand for ICAM-1. |
| Q24804747 | Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions |
| Q39257195 | Submicroscopic Plasmodium falciparum infections in pregnancy in Ghana |
| Q37678948 | Submicroscopic infection of placenta by Plasmodium produces Th1/Th2 cytokine imbalance, inflammation and hypoxia in women from north-west Colombia |
| Q50047198 | Submicroscopic placental infection by non-falciparum Plasmodium spp |
| Q34944523 | Sulfotransferases and sulfated oligosaccharides |
| Q34161839 | Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates |
| Q36261056 | Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions |
| Q50094534 | Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment. |
| Q30042328 | Targeted disruption of a ring-infected erythrocyte surface antigen (RESA)-like export protein gene in Plasmodium falciparum confers stable chondroitin 4-sulfate cytoadherence capacity |
| Q36683860 | Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein |
| Q47389892 | Targeting a DBL3gamma domain of the Plasmodium falciparum erythrocyte membrane protein 1 to the surface of Saccharomyces cerevisiae. |
| Q34482493 | Temporal expression and localization patterns of variant surface antigens in clinical Plasmodium falciparum isolates during erythrocyte schizogony |
| Q47926260 | The 3D7var5.2 (var COMMON) type var gene family is commonly expressed in non-placental Plasmodium falciparum malaria |
| Q36888570 | The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans |
| Q34461507 | The Malaria in Pregnancy Library: a bibliometric review. |
| Q60305299 | The Rough Guide to Monocytes in Malaria Infection |
| Q27650818 | The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria |
| Q36339851 | The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1. |
| Q39698908 | The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria |
| Q34170375 | The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains |
| Q35033540 | The conserved clag multigene family of malaria parasites: essential roles in host-pathogen interaction |
| Q33578805 | The effect of malaria and intestinal helminth coinfection on birth outcomes in Kumasi, Ghana |
| Q47923663 | The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth |
| Q80393538 | The effect of substitution of the N-acetyl groups of N-acetylgalactosamine residues in chondroitin sulfate on its degradation by chondroitinase ABC |
| Q35162525 | The epidemiology and consequences of maternal malaria: a review of immunological basis |
| Q38666558 | The immunological balance between host and parasite in malaria |
| Q41918908 | The impact of insecticide-treated bednets on malaria and anaemia in pregnancy in Kassena-Nankana district, Ghana: a randomized controlled trial |
| Q24644343 | The impact of malaria parasitism: from corpuscles to communities |
| Q26799240 | The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential? |
| Q43708209 | The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythrocytes |
| Q34470655 | The malaria-infected red blood cell: structural and functional changes |
| Q29615020 | The pathogenic basis of malaria |
| Q58732770 | The prevalence of submicroscopic Plasmodium falciparum gametocyte carriage and multiplicity of infection in children, pregnant women and adults in a low malaria transmission area in Southern Ghana |
| Q26862567 | The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research |
| Q33849067 | The role of Plasmodium falciparum var genes in malaria in pregnancy. |
| Q34541105 | The structural basis for CD36 binding by the malaria parasite |
| Q38290142 | The structural motif in chondroitin sulfate for adhesion of Plasmodium falciparum-infected erythrocytes comprises disaccharide units of 4-O-sulfated and non-sulfated N-acetylgalactosamine linked to glucuronic acid |
| Q74235566 | The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans |
| Q37909178 | Thrombomodulin and its role in inflammation. |
| Q33619319 | Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA. |
| Q34975870 | Transcribed var genes associated with placental malaria in Malawian women. |
| Q30828703 | Transcription of multiple var genes by individual, trophozoite-stage Plasmodium falciparum cells expressing a chondroitin sulphate A binding phenotype |
| Q35838605 | Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women |
| Q39546704 | Treating malaria in pregnancy in developing countries: priorities in clinical research and drug development |
| Q48036116 | Treatment and prevention of malaria in pregnancy: opportunities and challenges. |
| Q38287355 | Two DBLgamma subtypes are commonly expressed by placental isolates of Plasmodium falciparum |
| Q37554737 | Usefulness of a biomarker to identify placental dysfunction in the context of malaria |
| Q40670564 | VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria |
| Q90186732 | VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy |
| Q34706475 | VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria. |
| Q46608178 | VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein |
| Q34921119 | VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta |
| Q37742181 | Var gene expression and human Plasmodium pathogenesis |
| Q36478198 | Var transcription profiling of Plasmodium falciparum 3D7: assignment of cytoadherent phenotypes to dominant transcripts |
| Q36891434 | Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. |
| Q28744428 | Var2CSA minimal CSA binding region is located within the N-terminal region |
| Q37285731 | Variable var transition rates underlie antigenic variation in malaria |
| Q27972539 | Variant antigens of Plasmodium falciparum encoded by the var multigenic family are multifunctional macromolecules |
| Q47232540 | Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria |
| Q39365658 | Variant surface antigens of Plasmodium falciparum and their roles in severe malaria |
| Q37191299 | Variant-specific immunity to Plasmodium berghei in pregnant mice |
| Q33879876 | Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study |
| Q37246673 | What really happens to dendritic cells during malaria? |
| Q44168891 | Wheat germ cell-free technology for accelerating the malaria vaccine research |
| Q37426820 | World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. |
Search more.